News US starts the clock ticking on pharma tariffs The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.
News Novartis plans $23bn manufacturing, R&D spend in US Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.
News Pharma warns EU of "exodus to US" without reform Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.
News EU due to meet with pharma today to discuss tariffs European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs.
News Pharma in a spin as it tries to gauge Trump tariffs impact Pharmaceuticals are exempt from the tariffs revealed by President Donald Trump, for now, but the industry is bracing for what may come next.
News Pharma tariffs "will hurt US consumers most of all" If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
